Pharmaceutical composition for treating flu or hyperpyrexia caused by bacterial virus
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of bacterial virus and composition, applied in the field of pharmaceuticals, to achieve good thermal stability and antifreeze performance, good curative effect, and the effect of enhancing the body's immunity
Active Publication Date: 2011-09-28
ANIMAL MEDICINE SICHUAN FEIYANG
View PDF4 Cites 5 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
But so far, there is no literature report at home and abroad on the pharmaceutical composition made of baicalin, astr
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0016] Embodiment 1, the preparation of combining Chinese and Western medicine compound powder
[0017] (1) Prescription
[0018] A 1 : Astragalus polysaccharide (calculated as glucose) 1g, baicalin 2g, diclofenac 2g, soluble starch 95g;
[0019] A 2 : Astragalus polysaccharide (calculated as glucose) 1g, baicalin 3g, diclofenac 3g, soluble starch 93g;
[0020] A 3 : Astragalus polysaccharide (calculated as glucose) 2g, baicalin 4g, diclofenac 4g, soluble starch 90g;
[0021] (2) Preparation process
[0022] Mix the astragalus polysaccharide, baicalin and diclofenac in the prescribed amount evenly, then mix evenly with the soluble starch according to the method of equal-volume incremental dilution, and directly pack to prepare the compound powder combining traditional Chinese and western medicine.
Embodiment 2
[0023] Embodiment 2, the preparation of the pure Chinese medicine compound powder not containing diclofenac
[0024] (1) Prescription
[0025] B 1 : Astragalus polysaccharide (calculated as glucose) 1g, baicalin 2g, soluble starch 97g;
[0026] B 2 : Astragalus polysaccharide (calculated as glucose) 1g, baicalin 3g, soluble starch 96g;
[0027] B 3 : Astragalus polysaccharide (calculated as glucose) 2g, baicalin 4g, soluble starch 94g;
[0028] (2) Preparation process
[0029] The astragalus polysaccharide and baicalin in the prescribed amount were mixed evenly, and then mixed evenly with the soluble starch according to the method of equal volume incremental dilution, and directly divided into packages to obtain a pure Chinese medicine compound powder without diclofenac.
Embodiment 3
[0030] Embodiment 3, the preparation of diclofenac powder
[0031] (1) Prescription
[0032] C 1 : Diclofenac 2g, soluble starch 98g;
[0033] C 2 : Diclofenac 3g, soluble starch 97g;
[0034] C 3 : Diclofenac 4g, soluble starch 96g;
[0035] (2) Preparation process
[0036] Mix the diclofenac and soluble starch in the prescribed amount uniformly according to the equal-volume incremental dilution method, and directly pack to prepare the diclofenac powder.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to the field of pharmacy, and discloses a pharmaceutical composition for treating flu or hyperpyrexia caused by bacterial virus. The pharmaceutical composition is composed of 1 part of astragalus polysaccharides by weight, 2-3 parts of baicalin by weight and 2-3 parts of diclofenac sodium by weight, and can be prepared with pharmaceutically acceptable carriers according to the conventional methods of pharmaceutical preparations to obtain various dosage forms such as powder, granules, tablets, oral liquid or injection and the like suitable for application for patients. The pharmaceutical composition for treating flu or hyperpyrexia caused by bacterial virus has the advantages of treatment of both principal and secondary aspects of disease, good curative effect, quick effect-taking speed and the like, and the actions of the astragalus polysaccharides and the baicalin on protecting the liver and promoting urination can alleviate the side effects of the diclofenac sodium such as gastrointestinal reaction, hepatorenal damage and the like, and also can reduce the occurrence of delay of diseases because the strong abirritation of the diclofenac sodium covers up the clinical symptoms of inflammation, ulcer and the like.
Description
technical field [0001] The invention belongs to the field of pharmacy and relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating influenza or high fever symptoms caused by bacteria and viruses. Background technique [0002] Influenza is an acute respiratory infection caused by influenza virus. It is a highly contagious and fast-spreading disease. It is a common and frequently-occurring disease of humans or livestock. Fever is a common symptom of many diseases. The causes of fever can be divided into two categories: acute infectious diseases and acute non-infectious diseases. The former is the most common, such as respiratory tract, digestive tract, urinary tract and skin diseases caused by bacteria and viruses. infection etc. Currently, there are many medicaments for treating flu or high fever symptoms caused by bacterial viruses, such as single or compound preparations of traditional Chinese medicines, single or compound prepara...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more